CN Patent

CN105266952A — 一种抗青光眼手术中所用防术后结膜粘连的器材

Assigned to Beijing Tongren Hospital · Expires 2016-01-27 · 10y expired

What this patent protects

本发明公开了一种抗青光眼手术中所用器材，其包括由可吸收材料构成的植片和包裹在植片内的抗瘢痕药物。使用本发明，既可以通过可吸收材料的机械阻隔作用减少青光眼术后结膜下粘连，又能通过植片内包含的抗瘢痕药物在植片吸收中的缓慢释放起到防止粘连的作用，可以提高手术远期效果，降低小梁切除术的失败率。

USPTO Abstract

本发明公开了一种抗青光眼手术中所用器材，其包括由可吸收材料构成的植片和包裹在植片内的抗瘢痕药物。使用本发明，既可以通过可吸收材料的机械阻隔作用减少青光眼术后结膜下粘连，又能通过植片内包含的抗瘢痕药物在植片吸收中的缓慢释放起到防止粘连的作用，可以提高手术远期效果，降低小梁切除术的失败率。

Drugs covered by this patent

Patent Metadata

Patent number
CN105266952A
Jurisdiction
CN
Classification
—
Expires
2016-01-27
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Tongren Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.